国际路演：内分泌学和代谢疾病的新进展

IF 2 4区医学 Q3 ENDOCRINOLOGY & METABOLISM

Hormone and Metabolic Research Pub Date : 2024-04-11 DOI:10.1055/a-2256-7180

Charlotte Steenblock, Maha M. Saber-Ayad, Stefan R. Bornstein

{"title":"国际路演：内分泌学和代谢疾病的新进展","authors":"Charlotte Steenblock, Maha M. Saber-Ayad, Stefan R. Bornstein","doi":"10.1055/a-2256-7180","DOIUrl":null,"url":null,"abstract":"Dear Readers, Currently, there is a myriad of new developments in the field of endocrinology. In particular, significant strides have been made in the development of poly-agonists for the treatment of type 2 diabetes and obesity <xref idref=\"R2024-01-0045-0001\">1</xref>\n<xref idref=\"R2024-01-0045-0002\">2</xref>. Poly-agonists represent a novel therapeutic approach by combining multiple actions within a single molecule, targeting multiple receptors simultaneously to achieve enhanced efficacy. These innovative compounds aim to address the complex interplay of hormonal pathways involved in glucose regulation and metabolism, offering potential breakthroughs in the management of diabetes and obesity. ","PeriodicalId":12999,"journal":{"name":"Hormone and Metabolic Research","volume":"64 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"International Roadshow: New Advances in Endocrinology and Metabolic Diseases\",\"authors\":\"Charlotte Steenblock, Maha M. Saber-Ayad, Stefan R. Bornstein\",\"doi\":\"10.1055/a-2256-7180\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear Readers, Currently, there is a myriad of new developments in the field of endocrinology. In particular, significant strides have been made in the development of poly-agonists for the treatment of type 2 diabetes and obesity <xref idref=\\\"R2024-01-0045-0001\\\">1</xref>\\n<xref idref=\\\"R2024-01-0045-0002\\\">2</xref>. Poly-agonists represent a novel therapeutic approach by combining multiple actions within a single molecule, targeting multiple receptors simultaneously to achieve enhanced efficacy. These innovative compounds aim to address the complex interplay of hormonal pathways involved in glucose regulation and metabolism, offering potential breakthroughs in the management of diabetes and obesity. \",\"PeriodicalId\":12999,\"journal\":{\"name\":\"Hormone and Metabolic Research\",\"volume\":\"64 1\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hormone and Metabolic Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2256-7180\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormone and Metabolic Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2256-7180","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

亲爱的读者，目前，内分泌学领域取得了无数新进展。特别是在治疗 2 型糖尿病和肥胖症的多受体激动剂的开发方面取得了重大进展 12。多受体激动剂是一种新的治疗方法，它在单个分子中结合了多种作用，同时针对多个受体，从而提高疗效。这些创新化合物旨在解决参与葡萄糖调节和新陈代谢的荷尔蒙途径之间复杂的相互作用，为糖尿病和肥胖症的治疗提供潜在的突破。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

International Roadshow: New Advances in Endocrinology and Metabolic Diseases

Dear Readers,

Currently, there is a myriad of new developments in the field of endocrinology. In particular, significant strides have been made in the development of poly-agonists for the treatment of type 2 diabetes and obesity 1 2. Poly-agonists represent a novel therapeutic approach by combining multiple actions within a single molecule, targeting multiple receptors simultaneously to achieve enhanced efficacy. These innovative compounds aim to address the complex interplay of hormonal pathways involved in glucose regulation and metabolism, offering potential breakthroughs in the management of diabetes and obesity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hormone and Metabolic Research 医学-内分泌学与代谢

CiteScore

3.80

自引率

0.00%

发文量

125

审稿时长

3-8 weeks

期刊介绍： Covering the fields of endocrinology and metabolism from both, a clinical and basic science perspective, this well regarded journal publishes original articles, and short communications on cutting edge topics. Speedy publication time is given high priority, ensuring that endocrinologists worldwide get timely, fast-breaking information as it happens. Hormone and Metabolic Research presents reviews, original papers, and short communications, and includes a section on Innovative Methods. With a preference for experimental over observational studies, this journal disseminates new and reliable experimental data from across the field of endocrinology and metabolism to researchers, scientists and doctors world-wide.